A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Clinical trial NCT07317505 · RECRUITING

Trial details

NCT number: NCT07317505
Sponsor: Conjupro Biotherapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Cancer (Solid Tumors)

Start date: 2025-12-02
Primary completion: 2029-07-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.